Clinical Trials · NCT01031966
A Pilot Study to Evaluate ZADAXIN's® (Thymalfasin) Ability to Enhance Immune Response to the H1N1sw Influenza Vaccine
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- sigma-tau i.f.r. S.p.A.
- Enrollment
- 120
- Start date
- Nov 2009
- Locations
- 1 site, Italy
- Primary endpoint
- The measures of immunogenicity, as determined by HI; MN and SRH